Management of Pneumonia in Kidney Transplantation to Prevent Further Outbreak

The outbreak of Pneumocystis jirovecii pneumonia (PJP) among kidney transplant recipients is emerging worldwide. It is important to control nosocomial PJP infection. A delay in diagnosis and treatment increases the number of reservoir patients and the number of cases of respiratory failure and death...

Full description

Bibliographic Details
Main Authors: Norihiko Goto, Kenta Futamura, Manabu Okada, Takayuki Yamamoto, Makoto Tsujita, Takahisa Hiramitsu, Shunji Narumi, Yoshihiko Watarai
Format: Article
Language:English
Published: SAGE Publishing 2015-01-01
Series:Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine
Online Access:https://doi.org/10.4137/CCRPM.S23317
_version_ 1830227752684355584
author Norihiko Goto
Kenta Futamura
Manabu Okada
Takayuki Yamamoto
Makoto Tsujita
Takahisa Hiramitsu
Shunji Narumi
Yoshihiko Watarai
author_facet Norihiko Goto
Kenta Futamura
Manabu Okada
Takayuki Yamamoto
Makoto Tsujita
Takahisa Hiramitsu
Shunji Narumi
Yoshihiko Watarai
author_sort Norihiko Goto
collection DOAJ
description The outbreak of Pneumocystis jirovecii pneumonia (PJP) among kidney transplant recipients is emerging worldwide. It is important to control nosocomial PJP infection. A delay in diagnosis and treatment increases the number of reservoir patients and the number of cases of respiratory failure and death. Owing to the large number of kidney transplant recipients compared to other types of organ transplantation, there are greater opportunities for them to share the same time and space. Although the use of trimethoprim-sulfamethoxazole (TMP-SMX) as first choice in PJP prophylaxis is valuable for PJP that develops from infections by trophic forms, it cannot prevent or clear colonization, in which cysts are dominant. Colonization of P. jirovecii is cleared by macrophages. While recent immunosuppressive therapies have decreased the rate of rejection, over-suppressed macrophages caused by the higher levels of immunosuppression may decrease the eradication rate of colonization. Once a PJP cluster enters these populations, which are gathered in one place and uniformly undergoing immunosuppressive therapy for kidney transplantation, an outbreak can occur easily. Quick actions for PJP patients, other recipients, and medical staff of transplant centers are required. In future, lifelong prophylaxis may be required even in kidney transplant recipients.
first_indexed 2024-12-18T09:59:58Z
format Article
id doaj.art-346499bee71b4d18acf0e643f661a32c
institution Directory Open Access Journal
issn 1179-5484
language English
last_indexed 2024-12-18T09:59:58Z
publishDate 2015-01-01
publisher SAGE Publishing
record_format Article
series Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine
spelling doaj.art-346499bee71b4d18acf0e643f661a32c2022-12-21T21:11:41ZengSAGE PublishingClinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine1179-54842015-01-019s110.4137/CCRPM.S23317Management of Pneumonia in Kidney Transplantation to Prevent Further OutbreakNorihiko Goto0Kenta Futamura1Manabu Okada2Takayuki Yamamoto3Makoto Tsujita4Takahisa Hiramitsu5Shunji Narumi6Yoshihiko Watarai7Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.The outbreak of Pneumocystis jirovecii pneumonia (PJP) among kidney transplant recipients is emerging worldwide. It is important to control nosocomial PJP infection. A delay in diagnosis and treatment increases the number of reservoir patients and the number of cases of respiratory failure and death. Owing to the large number of kidney transplant recipients compared to other types of organ transplantation, there are greater opportunities for them to share the same time and space. Although the use of trimethoprim-sulfamethoxazole (TMP-SMX) as first choice in PJP prophylaxis is valuable for PJP that develops from infections by trophic forms, it cannot prevent or clear colonization, in which cysts are dominant. Colonization of P. jirovecii is cleared by macrophages. While recent immunosuppressive therapies have decreased the rate of rejection, over-suppressed macrophages caused by the higher levels of immunosuppression may decrease the eradication rate of colonization. Once a PJP cluster enters these populations, which are gathered in one place and uniformly undergoing immunosuppressive therapy for kidney transplantation, an outbreak can occur easily. Quick actions for PJP patients, other recipients, and medical staff of transplant centers are required. In future, lifelong prophylaxis may be required even in kidney transplant recipients.https://doi.org/10.4137/CCRPM.S23317
spellingShingle Norihiko Goto
Kenta Futamura
Manabu Okada
Takayuki Yamamoto
Makoto Tsujita
Takahisa Hiramitsu
Shunji Narumi
Yoshihiko Watarai
Management of Pneumonia in Kidney Transplantation to Prevent Further Outbreak
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine
title Management of Pneumonia in Kidney Transplantation to Prevent Further Outbreak
title_full Management of Pneumonia in Kidney Transplantation to Prevent Further Outbreak
title_fullStr Management of Pneumonia in Kidney Transplantation to Prevent Further Outbreak
title_full_unstemmed Management of Pneumonia in Kidney Transplantation to Prevent Further Outbreak
title_short Management of Pneumonia in Kidney Transplantation to Prevent Further Outbreak
title_sort management of pneumonia in kidney transplantation to prevent further outbreak
url https://doi.org/10.4137/CCRPM.S23317
work_keys_str_mv AT norihikogoto managementofpneumoniainkidneytransplantationtopreventfurtheroutbreak
AT kentafutamura managementofpneumoniainkidneytransplantationtopreventfurtheroutbreak
AT manabuokada managementofpneumoniainkidneytransplantationtopreventfurtheroutbreak
AT takayukiyamamoto managementofpneumoniainkidneytransplantationtopreventfurtheroutbreak
AT makototsujita managementofpneumoniainkidneytransplantationtopreventfurtheroutbreak
AT takahisahiramitsu managementofpneumoniainkidneytransplantationtopreventfurtheroutbreak
AT shunjinarumi managementofpneumoniainkidneytransplantationtopreventfurtheroutbreak
AT yoshihikowatarai managementofpneumoniainkidneytransplantationtopreventfurtheroutbreak